VE-cadherin is also expressed in a subset of acute lymphoblastic leukemia cells, where contributes to cell survival [12], and in a subset of cancer stem cells CD133+ in osteosarcoma, ovarian cancer and glioblastoma, contributing to vasculogenic mimicry by VEGF-independent tumour cell differentiation [13]. This evidence concerns the gene CDH5 and neoplasm.